News Focus
News Focus
icon url

plexrec

11/16/21 8:21 AM

#336098 RE: powerwalker #336096

"Al Sandrock makes an abrupt exit"--perhaps Al could be granted an interview at Anavex--the real deal !!!!!
icon url

Doc328

11/16/21 8:38 AM

#336101 RE: powerwalker #336096

Shame. I've met him several times and had dinner with him once. He is extremely bright and personable. I figured he would be one of the heads on the chopping block as BIIB would have been better off to just do a third 'tie-breaker' trial rather than push for accelerated approval and end up with a commercial flop.
icon url

tredenwater2

11/16/21 10:19 AM

#336124 RE: powerwalker #336096

His rare ability to see what others have overlooked and his tenacious drive to help others embodies what we strive to be as a company. The entire Board wishes to acknowledge with deep gratitude his tremendous contributions during his distinguished career.”



Too bad he “overlooked”, or better yet lost) AVXL’s drug for a possible promising treatment of MS. Maybe his “warmth” couldnt quite bring Dr. Missling to the bargaining table….thank God!

icon url

Rubyred77

11/16/21 12:46 PM

#336151 RE: powerwalker #336096

Might as well start the what if scenario…..

Then again. I think Missling is too much of a man with honor to take a position where Science and data isn’t top priority.

Imagine that. Buyout in the 8 figures and that spot.

Anavex gets to market, Biogen is in deep trouble R&D wise.